# GPT-5.6 Sol / inf-k01

Original final answer, shared by both scoring rounds.

## Useful conclusion

The supplied evidence supports only this conclusion: **the locus tagged by the lead SNP is associated with the GWAS trait**. It does **not** identify the lead SNP as causal or gene G as the effector gene. Because linked variants span both G and H, either gene—or another regulatory target—remains plausible.

The recommended next steps are to fine-map the association, test colocalization with relevant molecular traits, and perform allele- and gene-level functional perturbations. These steps answer different questions and are not interchangeable.

---

## Explicit evidence-to-inference-to-conclusion chain

### 1. GWAS association: localize an associated locus

**Evidence:** A well-controlled GWAS identifies a lead noncoding SNP near G; several linked variants span G and H. No functional or colocalization data are supplied (E1).

**Inference:** The lead SNP is the most statistically prominent measured or imputed marker at this locus. Its association may arise because:

- it is itself causal;
- it is correlated through linkage disequilibrium, or LD, with a causal variant;
- it tags more than one causal signal.

**Conclusion justified by E1:** A genetic signal in this region is associated with the trait.

**What GWAS cannot establish here:**

- that the lead SNP is the causal variant;
- that there is only one causal variant;
- that the variant acts through G;
- that proximity to G is mechanistically meaningful;
- that H is excluded;
- that the variant acts by altering gene expression rather than another molecular process.

“Lead SNP” is a statistical designation, not a functional one.

---

### 2. Linkage disequilibrium: explain why multiple variants share the signal

**Concept:** LD is correlation among nearby alleles in a population. If the causal allele and several neighboring variants are correlated, all can show similar trait associations.

**Application to this locus:** The linked variants spanning G and H mean that the GWAS may be unable to distinguish which correlated variant generated the association. Their locations near or within G and H do not by themselves identify either gene as causal.

**What linkage establishes:** It defines a set of variants that may statistically tag the same underlying signal.

**What linkage cannot establish:**

- which linked variant has the biological effect;
- which gene it regulates;
- whether the causal mechanism is regulatory;
- whether variants in the LD block are functionally equivalent.

Thus, linkage is the reason a locus-level association usually does not immediately resolve to a causal allele.

---

### 3. Fine mapping: prioritize candidate causal variants

**Proposed analysis:** Perform statistical fine mapping using variant-level association statistics and an LD model appropriate to the GWAS population. First assess whether the locus contains one or multiple conditionally independent association signals. Construct a credible set and assign variants relative statistical support under an explicitly stated model.

**Inference sought:** If one or a few variants retain substantially greater support after accounting for LD, they become stronger **candidate causal variants**. If the lead SNP has low fine-mapping support, it is likely functioning mainly as a tag.

**What fine mapping can establish:**

- which variants are statistically compatible with driving a signal;
- how uncertainty is distributed across linked variants;
- whether multiple association signals may exist, subject to model adequacy.

**What fine mapping cannot establish:**

- molecular causality by itself;
- the effector gene;
- the relevant cell type or biological mechanism;
- certainty that the highest-ranked variant is causal.

A credible set is not a list of experimentally proven causal variants. Resolution may remain poor if the linked variants have nearly indistinguishable association patterns.

**Unreported parameters that affect interpretation:** association effect sizes and standard errors, allele frequencies, sample size, imputation or genotyping quality, ancestry composition, LD reference, fine-mapping priors, credible-set threshold, and evidence for multiple signals. None are supplied in E1.

---

### 4. Colocalization: ask whether the trait and a molecular phenotype share a signal

**Proposed analysis:** Compare the GWAS signal with molecular-QTL signals—such as expression or splicing QTLs for G, H, and other genes—in biologically relevant tissues or cell states. The analysis should account for LD and possible multiple signals.

**Possible result and inference:** If the GWAS association and an eQTL for G are statistically consistent with the same causal variant, that would support a shared genetic signal and make G a stronger effector-gene candidate. Equivalent colocalization with H would support H. Distinct signals would argue against the tested molecular association explaining the GWAS signal.

**What colocalization can establish:** Statistical support that two association patterns are compatible with a shared causal variant rather than merely lying in the same broad region.

**What colocalization cannot establish:**

- that altered expression causes the trait;
- that the colocalized gene is the sole effector;
- the direction or timing of the disease-relevant mechanism;
- that absence of colocalization excludes a gene.

A negative result may reflect the wrong tissue, cell type, developmental stage, environmental condition, weak molecular-QTL power, or an untested molecular phenotype. A positive result may still reflect horizontal effects of the same variant on two outcomes rather than mediation of the GWAS effect through the measured expression trait.

**Current status:** No colocalization data are supplied, so neither G nor H receives support from this evidence class (E1).

---

### 5. Functional perturbation: test variant and gene mechanisms

Functional experiments should distinguish two related questions.

#### A. Variant-level perturbation

**Proposed experiment:** Introduce the candidate allele or edit the candidate regulatory sequence in a relevant cellular model, ideally in an otherwise matched genetic background. Measure effects on G, H, other nearby or connected genes, and an appropriate cellular phenotype.

Useful designs could include allele replacement, targeted disruption of the candidate element, or reporter assays, but endogenous-locus editing is generally more informative about native genomic context.

**What a positive result can establish:** The perturbed variant or element can alter a molecular or cellular phenotype in that experimental context.

**Limits:**

- reporter activity may not reproduce endogenous chromatin or long-range contacts;
- deleting an element is not equivalent to changing one nucleotide;
- editing artifacts or clonal effects can confound interpretation;
- an effect in a model may not occur in the relevant human tissue or state;
- lack of effect may reflect an inappropriate model or insensitive readout.

#### B. Gene-level perturbation

**Proposed experiment:** Increase or decrease G and H separately, using a perturbation magnitude and direction consistent with any observed allele effect. Test whether either manipulation reproduces the variant-associated molecular or cellular phenotype. Rescue experiments can ask whether restoring the candidate gene reverses the variant effect.

**What this can establish:** A gene is capable of mediating the measured phenotype in the tested system. Concordant variant editing, gene perturbation, and rescue would provide stronger evidence that the gene lies on the causal pathway.

**What it cannot establish alone:** Perturbing G or H does not prove that the GWAS variant naturally acts through that gene. Broad knockdown or overexpression may create nonphysiological effects.

**Current status:** No functional perturbation evidence is supplied (E1).

---

## Alternative causal models still compatible with E1

1. The lead SNP itself alters regulation of G.
2. Another linked variant alters G.
3. The lead SNP or another linked variant alters H.
4. A variant affects both G and H.
5. The signal acts through a more distant gene rather than either nearby gene.
6. The causal mechanism affects splicing, transcript stability, chromatin, or another phenotype not captured by expression.
7. Multiple causal variants or genes contribute to the locus signal.

---

## Overall conclusion

E1 establishes a **GWAS locus**, not a causal SNP–gene mechanism. Fine mapping would narrow the statistical candidate variants; colocalization would test whether the trait and a molecular phenotype share a genetic signal; functional perturbation would test whether candidate variants and genes produce the predicted biological effects. A credible causal model would require convergence across these steps, ideally including allele-specific editing, appropriate molecular readouts, gene perturbation, and rescue in a relevant biological context. Until such evidence is obtained, both G and H—and alternatives beyond them—must remain unresolved.
